Maxwell Life Science Profile
Key Indicators
- Authorised Capital ₹ 7.10 Cr
as on 18-06-2024
- Paid Up Capital ₹ 3.89 Cr
as on 18-06-2024
- Company Age 20 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 16.24 Cr
as on 18-06-2024
- Satisfied Charges ₹ 14.61 Cr
as on 18-06-2024
- Revenue 61.47%
(FY 2023)
- Profit 46.93%
(FY 2023)
- Ebitda -33.32%
(FY 2023)
- Net Worth 10.64%
(FY 2023)
- Total Assets 45.27%
(FY 2023)
About Maxwell Life Science
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.10 Cr and a paid-up capital of Rs 3.89 Cr.
The company currently has active open charges totaling ₹16.24 Cr. The company has closed loans amounting to ₹14.61 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Surana, Piyush Trivedi, Neetu Surana, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230MH2004PTC146536
- Company No.
146536
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Maxwell Life Science?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Surana  | Managing Director | 25-May-2004 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Piyush Trivedi | Director | 22-Apr-2024 | Current |
| Neetu Surana | Director | 30-Mar-2015 | Current |
| Rajendra Runwal | Director | 22-Apr-2024 | Current |
| Vijay Singhavi | Director | 22-Apr-2024 | Current |
Financial Performance and Corporate Structure Insights of Maxwell Life Science.
Maxwell Life Science Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 61.47% increase. The company also saw a substantial improvement in profitability, with a 46.93% increase in profit. The company's net worth Soared by an impressive increase of 10.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maxwell Life Science?
In 2023, Maxwell Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Bharat Co-Operative Bank(Mumbai) Ltd Creation Date: 01 Nov 2023 | ₹7.00 M | Open |
The Bharat Co-Operative Bank(Mumbai) Ltd Creation Date: 31 Jan 2023 | ₹1.25 Cr | Open |
The Bharat Co-Operative Bank(Mumbai) Ltd Creation Date: 25 May 2018 | ₹7.86 M | Open |
How Many Employees Work at Maxwell Life Science?
Maxwell Life Science has a workforce of 21 employees as of Jun 18, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maxwell Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxwell Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
